
About KMS Group
KMS Group is a publicly listed company based in Mumbai (India) founded in 1999 by Gaurang Prataprai Kanakia. Surgical adhesive tapes and wound dressings are developed by KMS. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Its chief executive, as recorded, is Gaurang Prataprai Kanakia. Its Indian entity Kms Medisurgi Limited reported revenue of βΉ12.22 Cr. KMS Group offers products and services including Advanced Wound Care, Surgical Tapes, and 5 Layer Silicone Foam Dressing. Its focus areas include Medical Devices and Wound Care Products.
Company details
KMS Group is focused on the production of surgical and advanced wound care products. The company is headquartered in Mumbai, India, with a manufacturing unit in Palghar. Operations are extended to both domestic and international markets through a widespread supply chain. Products are developed through market research to meet customer needs in the healthcare sector. Cost-efficient solutions are provided to ensure ease of usage and quality assurance. Long-term partnerships are cultivated to strengthen presence in the industry.
- Headquarters Mumbai, India
- Founders Gaurang Prataprai Kanakia
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website kmsgroup.in
- Legal Name Kms Medisurgi Ltd.
- Market Cap₹43.82 Cr
KMSMEDI · BSE
- Share Price₹132.80
0.00% today
- Revenue₹12.21 Cr
FY 2025-26 · -12.4% YoY
- EBITDA₹0.94 Cr
Margin 7.7%
- Net Profit₹0.25 Cr
FY 2025-26 · -41.9% YoY
- P/E (TTM)99.6x
P/B 5.4x
- ROE3.0%
ROCE 5.2%
- Debt / Equity0.10
Interest cover 29.8x
Associated legal entities of KMS Group
KMS Group is associated with 3 registered companies on The Company Check; the primary company is Kms Medisurgi Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kms Medisurgi Limited Listed CIN L51397MH1999PLC119118 | Active | 25 Mar 1999 | Mumbai, Maharashtra | ₹12.2 Cr | 19 | 8 | View details |
| Kms Stock Broking Company Private Limited CIN U67120MH2001PTC134185 | Active | 10 Dec 2001 | Mumbai, Maharashtra | ₹5.8 Cr | 2 | View details | |
| Kms Manufacturing Limited CIN U33100MH2017PLC290006 | Active | 30 Jan 2017 | Palghar, Maharashtra | ₹0.0 Cr | 3 | View details |
Products & Services of KMS Group
KMS Group offers a comprehensive portfolio of products and services, including Advanced Wound Care, Surgical Tapes, and 5 Layer Silicone Foam Dressing.
Advanced wound care products are developed for healing.
Surgical tapes are provided for medical securing needs.
Silicone foam dressings are offered for wound protection.
Board of directors of Kms Medisurgi Limited (KMS Group)
Kms Medisurgi Limited is the primary company behind KMS Group. The boards of the 3 registered companies of KMS Group currently have 10 directors; the longest-serving is Amrita Gaurang Kanakia, appointed in 2001. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Amrita Gaurang Kanakia DIN 00346183 | Director | 10 Dec 2001 | 24 yrs 10 mo | Kms Stock Broking Company Private Limited |
| Anand Prataprai Kanakia DIN 00285357 | Director | 10 Dec 2001 | 24 yrs 10 mo | Kms Stock Broking Company Private Limited |
| Hardik Rajnikant Bhatt DIN 07566870 | Director | 14 Jul 2016 | 10 yrs 3 mo | Kms Medisurgi Limited |
| Kamlesh Chunilal Rajani DIN 07588417 | Director | 11 Aug 2016 | 10 yrs 2 mo | Kms Medisurgi Limited |
| Rekha Devang Kanakia DIN 00346198 | Director | 30 Jan 2017 | 9 yrs 8 mo | Kms Manufacturing Limited |
| Gaurang Prataprai Kanakia DIN 00346180 | Director | 30 Jan 2017 | 9 yrs 8 mo | Kms Manufacturing Limited, Kms Medisurgi Limited |
| Siddharth Gaurang Kanakia DIN 07595098 | Director | 30 Jan 2017 | 9 yrs 8 mo | Kms Manufacturing Limited, Kms Medisurgi Limited |
| Pratik Pravin Tarpara DIN 08689556 | Director | 12 Feb 2020 | 6 yrs 8 mo | Kms Medisurgi Limited |
| Rohan Devang Kanakia DIN 09220915 | Director | 29 Jun 2021 | 5 yrs 4 mo | Kms Medisurgi Limited |
| Monali Gaurang Kanakia DIN 10135949 | Director | 03 May 2023 | 3 yrs 5 mo | Kms Medisurgi Limited |
People of KMS Group
1 people are tracked at KMS Group (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for KMS Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of KMS Group
KMS Group is a publicly listed company on the BSE with ticker symbol KMSMEDI in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Apr 2017
- Listed onBSE: 540468
- Listed entityKMS Medisurgi Ltd.
- Exchange sectorHealth technology
- ISININE870V01014
- Share price₹126.50 · 2026-05-11
- Market capitalisation₹41.7 Cr
- Price to earnings70.5
- EPS (diluted, trailing year)₹1.80
- Dividend yield0.04%
- Volume (last session)1,000
- Analyst consensusNo rating
Financials of KMS Group
Exchange-reported figures of Kms Medisurgi Limited, the listed company behind KMS Group (BSE: KMSMEDI).
Financial Highlights
FY 2025-26 Β· StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 12.21 | 13.94 | 13.88 | 11.03 | 10.32 | 7.51 | 10.34 |
| Revenue growth | -12.4% | +0.4% | +25.8% | +6.9% | +37.4% | -27.4% | - |
| EBITDA | 0.94 | 0.94 | 0.78 | 0.98 | 0.53 | 0.51 | 0.65 |
| EBITDA margin | +7.7% | +6.7% | +5.6% | +8.9% | +5.1% | +6.8% | +6.3% |
| Profit before tax | 0.34 | 0.60 | 0.60 | 0.68 | 0.29 | 0.25 | 0.17 |
| Net profit | 0.25 | 0.43 | 0.49 | 0.59 | 0.22 | 0.14 | 0.10 |
| Net profit margin | +2.1% | +3.1% | +3.5% | +5.4% | +2.1% | +1.9% | +1.0% |
| EPS (βΉ) | 0.74 | 1.33 | 1.38 | 1.74 | 0.65 | 0.37 | 0.34 |
| Balance sheet | |||||||
| Total assets | 9.09 | 9.00 | 8.20 | 8.22 | 7.66 | 7.48 | 7.45 |
| Net worth | 8.31 | 8.09 | 7.66 | 7.23 | 6.67 | 6.45 | 6.35 |
| Total debt | 0.77 | 0.91 | 0.54 | 0.99 | 0.99 | 1.03 | 1.11 |
| Cash & bank | 1.10 | 0.47 | 0.42 | 0.19 | 0.40 | 0.61 | 0.29 |
| Net working capital | 5.86 | 5.97 | 6.28 | 6.22 | 6.07 | 5.82 | 5.64 |
| Cash flow | |||||||
| Cash from operations | 1.51 | 0.74 | 1.21 | 0.46 | (0.07) | 0.53 | (0.84) |
| Cash from investing | (0.61) | (0.96) | (0.51) | (0.66) | (0.12) | (0.10) | 0.01 |
| Cash from financing | (0.26) | 0.27 | (0.47) | (0.01) | (0.02) | (0.11) | (0.06) |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 12.21 | 13.94 | 13.88 | 11.03 | 10.32 | 7.51 | 10.34 |
| Revenue growth | -12.4% | +0.4% | +25.8% | +6.9% | +37.4% | -27.4% | - |
| Other income | 0.01 | 0.03 | 0.09 | 0.02 | 0.05 | 0.10 | 0.00 |
| Total expenses | 11.27 | 13.00 | 13.10 | 10.05 | 9.79 | 7.00 | 9.69 |
| Employee cost | 1.16 | 1.05 | 1.17 | 0.96 | 0.79 | 0.68 | 0.76 |
| EBITDA | 0.94 | 0.94 | 0.78 | 0.98 | 0.53 | 0.51 | 0.65 |
| EBITDA margin | +7.7% | +6.7% | +5.6% | +8.9% | +5.1% | +6.8% | +6.3% |
| Depreciation | 0.47 | 0.27 | 0.25 | 0.32 | 0.29 | 0.33 | 0.41 |
| Interest | 0.14 | 0.10 | 0.02 | 0.00 | 0.00 | 0.03 | 0.07 |
| Profit before tax | 0.34 | 0.60 | 0.60 | 0.68 | 0.29 | 0.25 | 0.17 |
| Tax | 0.09 | 0.17 | 0.15 | 0.09 | 0.07 | 0.11 | 0.07 |
| Net profit | 0.25 | 0.43 | 0.49 | 0.59 | 0.22 | 0.14 | 0.10 |
| Net profit margin | +2.1% | +3.1% | +3.5% | +5.4% | +2.1% | +1.9% | +1.0% |
| EPS (βΉ) | 0.74 | 1.33 | 1.38 | 1.74 | 0.65 | 0.37 | 0.34 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 |
| Reserves & surplus | 5.01 | 4.79 | 4.36 | 3.93 | 3.37 | 3.15 | 3.05 |
| Shareholders' funds (net worth) | 8.31 | 8.09 | 7.66 | 7.23 | 6.67 | 6.45 | 6.35 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.13 |
| Unsecured loans | 0.77 | 0.91 | 0.54 | 0.99 | 0.99 | 0.98 | 0.98 |
| Total debt | 0.77 | 0.91 | 0.54 | 0.99 | 0.99 | 1.03 | 1.11 |
| Total liabilities | 9.09 | 9.00 | 8.20 | 8.22 | 7.66 | 7.48 | 7.45 |
| Assets | |||||||
| Gross block | 7.26 | 5.54 | 5.24 | 5.93 | 5.27 | 5.15 | 4.98 |
| Net block | 2.93 | 1.68 | 1.65 | 1.82 | 1.48 | 1.65 | 1.81 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 2.54 | 2.52 | 2.09 | 0.92 | 0.97 | 0.67 | 1.35 |
| Sundry debtors | 3.22 | 4.24 | 5.78 | 6.54 | 6.54 | 6.28 | 5.50 |
| Cash & bank balances | 1.10 | 0.47 | 0.42 | 0.19 | 0.40 | 0.61 | 0.29 |
| Loans & advances | 0.46 | 0.08 | 0.64 | 0.08 | 0.33 | 0.12 | 0.15 |
| Total current assets | 7.32 | 7.31 | 8.93 | 7.73 | 8.24 | 7.68 | 7.29 |
| Total current liabilities | 1.46 | 1.34 | 2.65 | 1.51 | 2.17 | 1.86 | 1.65 |
| Net working capital | 5.86 | 5.97 | 6.28 | 6.22 | 6.07 | 5.82 | 5.64 |
| Total assets | 9.09 | 9.00 | 8.20 | 8.22 | 7.66 | 7.48 | 7.45 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.47 | 0.42 | 0.19 | 0.40 | 0.61 | 0.29 | 1.18 |
| Net cash from operating activities | 1.51 | 0.74 | 1.21 | 0.46 | (0.07) | 0.53 | (0.84) |
| Net cash from investing activities | (0.61) | (0.96) | (0.51) | (0.66) | (0.12) | (0.10) | 0.01 |
| Net cash from financing activities | (0.26) | 0.27 | (0.47) | (0.01) | (0.02) | (0.11) | (0.06) |
| Net change in cash | 0.64 | 0.05 | 0.23 | (0.21) | (0.21) | 0.32 | (0.88) |
| Closing cash | 1.10 | 0.47 | 0.42 | 0.19 | 0.40 | 0.61 | 0.29 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -12.4% | +0.4% | +25.8% | +6.9% | +37.4% | -27.4% | - |
| EBITDA growth | 0.0% | +20.5% | -20.4% | +84.9% | +3.9% | -21.5% | - |
| PBT growth | -43.3% | 0.0% | -11.8% | +134.5% | +16.0% | +47.1% | -15.0% |
| Net income growth | -41.9% | -12.2% | -17.0% | +168.2% | +57.1% | +40.0% | - |
| Revenue CAGR (3Y) | +3.5% | +10.5% | +22.7% | +2.2% | +1.5% | +0.9% | +9.4% |
| EBITDA CAGR (3Y) | -1.4% | +21.1% | +15.2% | +14.7% | +20.9% | +2.8% | -11.3% |
| Profitability & leverage | |||||||
| Net income margin | +2.1% | +3.1% | +3.2% | +5.4% | +2.1% | +1.9% | +1.0% |
| Return on capital employed | +5.2% | +8.3% | +7.6% | +8.3% | +3.8% | +3.5% | +3.4% |
| Return on net worth | +3.1% | +5.6% | +6.0% | +8.2% | +3.4% | +1.9% | +1.8% |
| Debt / equity | 0.10 | 0.09 | 0.10 | 0.14 | 0.15 | 0.17 | 0.18 |
| Long-term debt / equity | 0.10 | 0.09 | 0.10 | 0.14 | 0.15 | 0.17 | 0.18 |
| Interest cover | 29.79 | 14.93 | 3.77 | 0.00 | 0.00 | 16.67 | 29.17 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.91 | 2.59 | 2.49 | 1.97 | 1.98 | 1.48 | 2.08 |
| Inventory turnover | 4.83 | 6.05 | 9.22 | 11.67 | 12.59 | 7.44 | 6.54 |
| Debtors turnover | 3.27 | 2.78 | 2.25 | 1.69 | 1.61 | 1.28 | 1.96 |
| EPS (βΉ) | 0.74 | 1.33 | 1.38 | 1.74 | 0.65 | 0.37 | 0.34 |
| Dividend per share (βΉ) | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Book value per share (βΉ) | 25.20 | 24.50 | 23.22 | 21.89 | 20.21 | 19.56 | 19.23 |
Web traffic of KMS Group
The website of KMS Group (kmsgroup.in) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 31.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kms Group
Complete news archive for KMS Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KMS Group
KMS Group was founded in 1999.
KMS Group is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Gaurang Prataprai Kanakia is the CEO of KMS Group, as recorded in our data. They have also founded this company.
The primary company behind KMS Group, Kms Medisurgi Limited, reported revenue of βΉ12.22 Cr for FY 2026, down 12% year on year.
KMS Group is focused on the production of surgical and advanced wound care products. The company is headquartered in Mumbai, India, with a manufacturing unit in Palghar. Operations are extended to both domestic and international markets through a widespread supply chain. Products are developed through market research to meet customer needs in the healthcare sector. Cost-efficient solutions are provided to ensure ease of usage and quality assurance. Long-term partnerships are cultivated to strengthen presence in the industry.
KMS Group offers Advanced Wound Care, Surgical Tapes, and 5 Layer Silicone Foam Dressing.
Yes, KMS Group is publicly traded on BSE under the ticker symbol KMSMEDI.
KMS Group is associated with 3 legal entities: Kms Medisurgi Limited, Kms Manufacturing Limited, Kms Stock Broking Company Private Limited.
The legal entities of KMS Group currently have 10 directors, including Rekha Devang Kanakia, Gaurang Prataprai Kanakia, Siddharth Gaurang Kanakia and others.
